1. Legal requirement: Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol
Management of serious breaches of clinical trials authorised in the Europe Union (EU)/ European Economic Area (EEA) is defined by Regulation (EU) No 536/2014, which states in Article 52:
“1. The sponsor shall notify the Member States concerned about a serious breach of this Regulation or of the version of the protocol applicable at the time of the breach through the EU portal without undue delay but not later than seven days of becoming aware of that breach.
2. For the purposes of this Article, a ‘serious breach’ means a breach likely to affect to a significant degree the safety and rights of a subject or the reliability and robustness of the data generated in the clinical trial.”
© European Medicines Agency, 2021
Clinical Research News
Upcoming Clinical Research Training and Conferences
-
on demandACROSS Global Training AcademyOnline
-
29 September 2023 – 02 October 2024SCDM (Society of Clinical Data Management)United States
-
21 – 23 May 2024InformaBelgium
-
03 – 04 June 2024The Society for Clinical Research Sites (SCRS)United States
-
16 – 17 July 2024The Society for Clinical Research Sites (SCRS)Australia
-
27 September – 29 October 2024The Society for Clinical Research Sites (SCRS)United States
Prossimi studi clinici
-
Case Comprehensive Cancer CenterNon ancora reclutamentoCancro ovarico epiteliale
-
University of California, San FranciscoAmerican Society of TransplantationReclutamentoTUTTO Pediatrico | Trapianto di fegato; ComplicazioniStati Uniti
-
University of California, San DiegoMayo Clinic; National Heart, Lung, and Blood Institute (NHLBI); Yale University; Brigham... e altri collaboratoriReclutamentoAsma da moderato a graveStati Uniti
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); New Mexico State University; National Cancer Institute...Non ancora reclutamentoCarcinoma correlato al fumo di sigarettaStati Uniti
-
Diabetes Foundation, IndiaNational Diabetes Obesity and Cholesterol FoundationReclutamentoDiabete mellito di tipo 2 con complicanzeIndia
-
Bandırma Onyedi Eylül UniversityNon ancora reclutamento
-
Centre Hospitalier Universitaire de Saint EtienneLEO Pharma; Ligue contre le cancer, France; Diagnostica StagoNon ancora reclutamentoCancro | Trombosi | Embolia polmonareFrancia
-
Massachusetts General HospitalNon ancora reclutamentoSchizofreniaStati Uniti
-
Aswan UniversityReclutamentoDexmedetomidina | Blocco erettore della spina dorsaleEgitto
-
University Hospital TuebingenReclutamentoSarcoma dei tessuti molli adultoGermania
-
Tolmar Inc.ICON plcNon ancora reclutamento
-
Peking University First HospitalReclutamento